Alternative Data for Progyny
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 24 | Sign up | Sign up | Sign up |
| Sentiment | 88 | Sign up | Sign up | Sign up |
| Webpage traffic | 210,000 | Sign up | Sign up | Sign up |
| Employee Rating | 54 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| App Downloads | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 28 | Sign up | Sign up | Sign up |
| Facebook Followers | 2,351 | Sign up | Sign up | Sign up |
| Instagram Followers | 8,812 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 2,457 | Sign up | Sign up | Sign up |
| X Followers | 2,088 | Sign up | Sign up | Sign up |
| X Mentions | 4 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 15,000 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 43 | Sign up | Sign up | Sign up |
| Linkedin Employees | 880 | Sign up | Sign up | Sign up |
| NPS | 31 | Sign up | Sign up | Sign up |
About Progyny
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States.
| Price | $24.25 |
| Target Price | Sign up |
| Volume | 1,180,000 |
| Market Cap | $2.17B |
| Year Range | $18.01 - $28.42 |
| Dividend Yield | 0% |
| PE Ratio | 40.68 |
| Analyst Rating | 36% buy |
| Industry | Health Care Services |
In the news
 |
Progyny just upgraded at Citizens, here's whyJanuary 20 - Thefly.com |
 |
Progyny, Inc. (PGNY) Presents at 44th Annual J.P. Morgan Healthcare Conference - SlideshowJanuary 12 - SeekingAlpha |
|
Progyny, Inc. (PGNY) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptJanuary 12 - SeekingAlpha |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 313M | 241M | 73M | 14M | 25M | 0.450 |
| Q2 '25 | 333M | 254M | 79M | 17M | 28M | 0.480 |
| Q1 '25 | 324M | 248M | 76M | 15M | 25M | 0.480 |
| Q4 '24 | 298M | 235M | 63M | 11M | 17M | 0.420 |
| Q3 '24 | 287M | 227M | 59M | 10M | 13M | 0.400 |
Insider Transactions View All
| Livingston Mark S. filed to sell 46,983 shares at $25.5. December 15 '25 |
| Swartz Allison filed to sell 72,719 shares at $24.6. December 8 '25 |
| Livingston Mark S. filed to sell 47,921 shares at $25.5. December 4 '25 |
| Swartz Allison filed to sell 73,657 shares at $26.9. December 2 '25 |
| Livingston Mark S. filed to sell 48,358 shares at $25.5. November 19 '25 |
Similar companies
Read more about Progyny (PGNY) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, app downloads, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - Progyny
The Market Cap of Progyny is $2.17B.
As of today, Progyny's PE (Price to Earnings) ratio is 40.68.
Currently, the price of one share of Progyny stock is $24.25.
The PGNY stock price chart above provides a comprehensive visual representation of Progyny's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Progyny shares. Our platform offers an up-to-date PGNY stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Progyny (PGNY) does not offer dividends to its shareholders. Investors interested in Progyny should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Progyny are Abbott Laboratories, HCA Healthcare, Cardinal Health, Henry Schein, and Idexx Laboratories.
